Skip to main content
GutCited

研究流程

477 来自同行评审研究的图表

全部 Psyllium Husk Bifidobacterium lactis Fructooligosaccharides (FOS) Lactobacillus plantarum Peppermint Oil Pancreatic Enzymes (Pancrelipase) Curcumin Vitamin A Medium-Chain Triglycerides (MCT Oil) Galactooligosaccharides (GOS) Lactobacillus gasseri Aloe Vera (Inner Leaf Gel) Alpha-Galactosidase Vitamin D L-Glutamine Inulin Ginger Lactase Berberine Omega-3 Fatty Acids (EPA/DHA) Bovine Colostrum Zinc Bifidobacterium bifidum Butyrate (Sodium/Calcium Butyrate) Bacillus coagulans Saccharomyces boulardii Lactobacillus acidophilus N-Acetyl Cysteine (NAC) Bifidobacterium longum
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 8
Figure 8

Integrated gut microbiome and metabolome analyses identified fecal biomarkers for bowel movement …

Fig. 1. The overall distribution of anti-measles antibody (IgM) in patients’ sera (n = 100).
Figure 1

Fig. 1. The overall distribution of anti-measles antibody (IgM) in patients’ sera (n = 100).

The Resurgence of Measles Infection and its Associated Complications in Early Childhood …

Fig. 2. Gender distribution of measles complications (Percentage).
Figure 2

Fig. 2. Gender distribution of measles complications (Percentage).

The Resurgence of Measles Infection and its Associated Complications in Early Childhood …

Fig. 3. Number of confirmed measles cases from 2006 to 2019 in Pakistan (WHO 2019; updates).
Figure 3

Fig. 3. Number of confirmed measles cases from 2006 to 2019 in Pakistan (WHO 2019; updates).

The Resurgence of Measles Infection and its Associated Complications in Early Childhood …

Fig. 4. Distribution of measles complications among measles-vaccinated and unvaccinated children.
Figure 4

Fig. 4. Distribution of measles complications among measles-vaccinated and unvaccinated children.

The Resurgence of Measles Infection and its Associated Complications in Early Childhood …

Figure 2. Adhesive properties and mechanism of action of LP299v probiotic strain [28, 30, 31]. Some mechanisms of probiotic action might be widespread; others frequently observed, yet others may be rare and characteristic for only a few strains of a given
Figure 1

Figure 2. Adhesive properties and mechanism of action of LP299v probiotic strain [28, 30, 31]. Some mechanisms of probiotic action might be widespread; others frequently observed, yet others may be …

Probiotics in irritable bowel syndrome - is the quest for the right …

FIGURE 1. Consort flow diagram of patient enrollment, allocation, and analysis.
Figure 2 Flowchart

CONSORT flow diagram detailing patient enrollment, randomization, allocation to treatment and control groups, and final analysis in the IBS-C kombucha intervention trial. Dropout rates and reasons for exclusion are documented at each stage.

Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins …

FIGURE 2. Study design.
Figure 3 Diagram

Study design schematic illustrating the intervention protocol, including kombucha drink composition (with inulin and vitamin supplementation), dosing schedule, and assessment timepoints across the trial period.

Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins …

FIGURE 3. The severity of bloating in patients of the studied groups.
Figure 4 Chart

Comparison of bloating severity scores between the kombucha intervention group and control group over the study period. Reductions in bloating severity suggest the enriched kombucha drink may be associated with symptomatic improvement in IBS-C patients.

Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins …

FIGURE 4. The severity of the feeling of incomplete emptying in patients of the studied groups.
Figure 5 Chart

Assessment of the feeling of incomplete bowel emptying in IBS-C patients receiving the kombucha-based drink versus controls. Severity scores at multiple timepoints indicate a trend toward improvement in the intervention group.

Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins …

FIGURE 5. Stool frequency of the studied groups.
Figure 6 Chart

Stool frequency data comparing the kombucha intervention and control groups across the study timeline. Increased bowel movement frequency in the treatment group suggests a potential benefit of the inulin- and vitamin-enriched kombucha formulation.

Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins …

FIGURE 6. Stool consistency of the studied groups.
Figure 7 Chart

Stool consistency scores evaluated using the Bristol Stool Scale for both study groups. Improvements in stool consistency over the intervention period suggest the kombucha-based drink may help normalize bowel habits in IBS-C patients.

Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins …

2.3. Study Design and Product
Figure 2 Diagram

Study product composition and dosing protocol for heat-treated Bifidobacterium longum CECT 7347 are described, detailing the intervention design for this gastrointestinal symptom trial.

Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, …

Figure 3
Figure 3 Chart

Gastrointestinal symptom scores at baseline and follow-up are compared between the postbiotic HT-ES1 and placebo groups, showing changes in digestive comfort over the intervention period.

Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, …

Figure 4
Figure 4 Chart

Individual gastrointestinal symptom subscores including bloating, abdominal pain, and flatulence are presented for postbiotic and placebo groups across the study timepoints.

Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, …

Figure 1
Figure 1 Flowchart

Participant enrollment and randomization flow for the double-blind trial evaluating α-galactosidase in children with gas-related symptoms is depicted.

Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a …

Figure 2
Figure 2 Chart

Frequency of gas-related episodes is compared between children receiving α-galactosidase and placebo over the treatment period, indicating changes in symptom burden.

Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a …

Figure 3
Figure 3 Chart

Overall symptom severity scores for gas-related complaints in children are tracked across the study timeline, comparing the α-galactosidase and placebo arms.

Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a …

FIGURE 1 Risk of bias summary of randomised controlled trials examining the effect of biophenol-rich nutraceuticals on gastrointestinal symptoms and related outcomes in adults with inflammatory related gastrointestinal conditions
Figure 1

FIGURE 1 Risk of bias summary of randomised controlled trials examining the effect of biophenol-rich nutraceuticals on gastrointestinal symptoms and related outcomes in adults with inflammatory related gastrointestinal conditions

Efficacy and safety of biophenol-rich nutraceuticals in adults with inflammatory gastrointestinal diseases …

Figure 2
Figure 2

Efficacy and safety of biophenol-rich nutraceuticals in adults with inflammatory gastrointestinal diseases …

Figure 1. Experimental design. SCS: sodium carboxymethyl cellulose; BE: berberine and evodiamine; FF: fenofibrate.
Figure 5 Flowchart

The experimental design outlines the group allocation including sodium carboxymethyl cellulose control, berberine-evodiamine combination, and fenofibrate positive control arms.

The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver …

Figure 6
Figure 6 Chart

Gut microbiota composition analyzed by 16S rRNA sequencing reveals distinct community structures across treatment groups, with the combination therapy restoring microbial diversity.

The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver …

Figure 7
Figure 7 Chart

Alpha diversity indices of gut microbiota are compared across groups, indicating that berberine and evodiamine co-administration partially reverses high-fat diet-induced dysbiosis.

The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver …

Figure 8
Figure 8 Chart

Key bacterial taxa differentially abundant between treatment groups are identified, with specific genera associated with improved metabolic outcomes in the combination therapy arm.

The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver …

第 12 页，共 20 页